Study to Evaluate Safety and Tolerability of GX-I7 in Patients With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT03478995 · COMPLETED
Trial details
- NCT number
- NCT03478995
- Sponsor
- Genexine, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-05
- Primary completion
- 2020-03-16
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.